What is Calysta?
Established in 2011 and headquartered in California, Calysta is at the forefront of developing and manufacturing protein ingredients from novel sources. The company's technology aims to address the increasing demand for food without exacerbating environmental damage, positioning it as a key player in the sustainable food technology sector. Calysta's work is crucial for feeding the planet responsibly, leveraging biotechnology to create essential protein components.
How much funding has Calysta raised?
Calysta has raised a total of $152M across 5 funding rounds:
Series A
$3M
Series B
$10M
Series C
$30M
Series D
$79M
Corporate Investment
$30M
Series A (2013): $3M with participation from Pangaea Ventures
Series B (2015): $10M led by Aqua-Spark, Pangaea Ventures, Riverwood Capital, and Walden
Series C (2016): $30M supported by Mitsui & Co. and Cargill
Series D (2017): $79M featuring Municipal Employee Retirement System (MERS) of Michigan, Cargill, Temasek, Aqua-Spark, BP Ventures, Mitsui & Co., Adisseo, Pangaea Ventures, Walden International, and WTI
Corporate Investment (2019): $30M backed by BP Ventures
Key Investors in Calysta
Municipal Employee Retirement System (MERS) of Michigan
The Municipal Employees’ Retirement System (MERS) of Michigan is an independent retirement services company that provides professional retirement solutions, focusing on financial wellness and retirement planning for municipal employees.
Cargill
Cargill Meat Solutions Corporation is a leading processor and distributor of fresh beef, pork and turkey, plus cooked and marinated meats, committed to providing great-tasting meat to customers worldwide.
Temasek
Temasek is a global investment company headquartered in Singapore, acting as a generational investor seeking to make a difference with tomorrow in mind.
What's next for Calysta?
With substantial enterprise-level backing and a recent strategic investment, Calysta is poised for significant expansion and further development of its protein ingredient technologies. This capital infusion is expected to accelerate manufacturing capabilities, broaden market reach, and potentially fund further research into sustainable food sources. The company's trajectory suggests a move towards scaling its operations to meet global demand, reinforcing its commitment to environmental sustainability and food security.
See full Calysta company page
